» Articles » PMID: 33090307

Hypericum Perforatum L.: a Medicinal Plant with Potential As a Curative Agent Against Obesity-associated Complications

Overview
Journal Mol Biol Rep
Specialty Molecular Biology
Date 2020 Oct 22
PMID 33090307
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is a low-grade inflammatory disease that is getting increasingly common among adults and children and causes different complications. Insulin resistance, Type II diabetes, atherosclerosis, metabolic syndrome and hypertension are among the major health problems, that are associated with obesity. Some medications are used to treat obese individuals and metabolic surgery is recommended, if appropriate, for individuals with a BMI ≥ 40. Due to the fact that medications and metabolic surgery are not tolerated by all, researchers focus on alternative therapies. Medicinal plants comprise the most important group of these alternative treatments. Hypericum perforatum L. is the medicinal plant, which we focused on in this study. Hypericum perforatum L. has been recognized as a medicinally valuable plant for over 2000 years. It has been used for generations to treat anxiety, depression, insomnia, gastritis, hemorrhoids, wounds, and burns. Recent studies have indeed shown promising effects for the treatment of obesity. In this study, 3T3-L1 adipocytes were used to mimic the adipocyte differentiation associated with obesity in cellular terms. Lipoprotein lipase (Lpl), Diacylglycerol-O-acyltransferase 1 (Dgat1), Fatty acid synthase (Fasn) markers were used to study the lipid accumulation, and Collagen V (ColV) was used to study cell elasticity to investigate the relationship of the effects of the administration of Hypericum perforatum L. with obesity.

Citing Articles

The Potential of Selected Plants and Their Biologically Active Molecules in the Treatment of Depression and Anxiety Disorders.

Urbanska N, Ashaolu T, Mattova S, Simko P, Kiskova T Int J Mol Sci. 2025; 26(5).

PMID: 40076986 PMC: 11900588. DOI: 10.3390/ijms26052368.


Healing Effect of in Burn Injuries.

Hamedi Z, Manafi A, Hashemi S, Mehrabani D, Seddighi A, Tanideh N World J Plast Surg. 2024; 13(3):57-65.

PMID: 39665012 PMC: 11629761. DOI: 10.61186/wjps.13.3.57.


Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management.

Shaik Mohamed Sayed U, Moshawih S, Goh H, Kifli N, Gupta G, Singh S Front Pharmacol. 2023; 14:1182937.

PMID: 37408757 PMC: 10318930. DOI: 10.3389/fphar.2023.1182937.


L. and the Underlying Molecular Mechanisms for Its Choleretic, Cholagogue, and Regenerative Properties.

Mohagheghzadeh A, Badr P, Mohagheghzadeh A, Hemmati S Pharmaceuticals (Basel). 2023; 16(6).

PMID: 37375834 PMC: 10300974. DOI: 10.3390/ph16060887.


The effects of the Rheum ribes plant extract on inflammation, extracellular matrix remodeling, and obesity suggest a therapeutic potential.

Kaya H, Tokgoz H, Unal R, Altan F Mol Biol Rep. 2023; 50(6):5223-5232.

PMID: 37126207 DOI: 10.1007/s11033-023-08478-2.


References
1.
Ye J . Mechanisms of insulin resistance in obesity. Front Med. 2013; 7(1):14-24. PMC: 3936017. DOI: 10.1007/s11684-013-0262-6. View

2.
Koren D, Taveras E . Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome. Metabolism. 2018; 84:67-75. DOI: 10.1016/j.metabol.2018.04.001. View

3.
Harris C, Haas J, Streeper R, Stone S, Kumari M, Yang K . DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes. J Lipid Res. 2011; 52(4):657-67. PMC: 3284159. DOI: 10.1194/jlr.M013003. View

4.
Yen C, Stone S, Koliwad S, Harris C, Farese Jr R . Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res. 2008; 49(11):2283-301. PMC: 3837458. DOI: 10.1194/jlr.R800018-JLR200. View

5.
Sadur C, Yost T, Eckel R . Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity. J Clin Endocrinol Metab. 1984; 59(6):1176-82. DOI: 10.1210/jcem-59-6-1176. View